| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 65,981 | 71,963 | 69,658 | 67,032 | | Cost of Revenue | 54,622 | 59,142 | 56,703 | 54,158 | | | Gross Profit | 11,359 | 12,821 | 12,955 | 12,874 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,535 | 6,697 | 6,280 | 5,861 | | Non Recurring |
-
|
-
|
-
| 2,745 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,824 | 6,124 | 6,675 | 4,268 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 107 | 44 | 136 | 22 | | Earnings Before Interest And Taxes | 3,931 | 6,168 | 6,811 | 4,290 | | Interest Expense | 1,152 | 1,257 | 1,229 | 1,290 | | Income Before Tax | 2,779 | 4,911 | 5,582 | 3,000 | | Income Tax Expense | 580 | 1,479 | 1,597 | 148 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,199 | 3,432 | 3,985 | 2,852 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 33 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,199 | 3,432 | 3,985 | 2,885 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,199 | $3,432 | $3,985 | $2,885 |
|
0.12% Nasdaq 
0.03%
Income Statement
